PLEURAL FLUID ANALYSIS IN MALIGNANT MESOTHELIOMA - PROGNOSTIC IMPLICATIONS

被引:27
|
作者
GOTTEHRER, A
TARYLE, DA
REED, CE
SAHN, SA
机构
[1] MED UNIV S CAROLINA,DIV PULM & CRIT CARE MED,CHARLESTON,SC 29705
[2] MED UNIV S CAROLINA,DIV CARDIOTHORAC SURG,CHARLESTON,SC 29705
[3] UNIV COLORADO,HLTH SCI CTR,DENVER,CO 80262
关键词
D O I
10.1378/chest.100.4.1003
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Pleural fluid characteristics of 26 patients diagnosed with malignant mesothelioma over an 18-year period were reviewed and compared with those of patients with effusions due to other malignancies. Survival from time of initial thoracentesis was directly correlated with pleural pH and decreased pleural fluid/serum glucose ratios but was not related to protein or LDH concentration. Decreased pleural fluid pH was statistically related to a decreased pleural fluid/serum glucose ratio. Patients with low pH (< 7.30) pleural effusions had statistically decreased mean survival and decreased mean pleural fluid/serum glucose ratios compared with patients with normal pH (greater-than-or-equal-to 7.30). Patients with malignant mesothelioma pleural effusions had statistically decreased mean pleural fluid pH compared with patients with other malignant pleural effusions. Decreased levels of pleural fluid pH and pleural fluid/serum glucose ratios have negative prognostic significance and probably correlate with the degree of tumor bulk affecting the pleural surface.
引用
收藏
页码:1003 / 1006
页数:4
相关论文
共 50 条
  • [1] Pleural fluid findings as prognostic factors for malignant pleural mesothelioma
    Gonlugur, Tanseli Efeoglu
    Gonlugur, Ugur
    [J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2008, 22 (05) : 334 - 336
  • [2] Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma
    Thylén, A
    Hjerpe, A
    Martensson, G
    [J]. CANCER, 2001, 92 (05) : 1224 - 1230
  • [3] Assessment of interferon-γ in pleural fluid as a prognostic factor of survival in malignant pleural mesothelioma
    Beatrice Dozin
    Grazia Carbotti
    Silvio Roncella
    Paola Ferro
    Paolo Dessanti
    Pier Aldo Canessa
    Silvano Ferrini
    Marina Fabbi
    [J]. Cancer Immunology, Immunotherapy, 2021, 70 : 3349 - 3355
  • [4] Assessment of interferon-γ in pleural fluid as a prognostic factor of survival in malignant pleural mesothelioma
    Dozin, Beatrice
    Carbotti, Grazia
    Roncella, Silvio
    Ferro, Paola
    Dessanti, Paolo
    Canessa, Pier Aldo
    Ferrini, Silvano
    Fabbi, Marina
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (11) : 3349 - 3355
  • [5] Prognostic factors for malignant pleural mesothelioma
    Fraser J. H. Brims
    Nick A. Maskell
    [J]. Current Respiratory Care Reports, 2013, 2 (2): : 100 - 108
  • [6] Prognostic factors for malignant pleural mesothelioma
    Brims, Fraser J. H.
    Maskell, Nick A.
    [J]. CURRENT PULMONOLOGY REPORTS, 2013, 2 (02) : 100 - 108
  • [7] Prognostic factors in malignant pleural mesothelioma
    Davidson, Ben
    [J]. HUMAN PATHOLOGY, 2015, 46 (06) : 789 - 804
  • [8] The therapeutic implications of the genomic analysis of malignant pleural mesothelioma
    Marjorie G. Zauderer
    [J]. Nature Communications, 12
  • [9] The therapeutic implications of the genomic analysis of malignant pleural mesothelioma
    Zauderer, Marjorie G.
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [10] Prognostic Factors in Malignant Pleural Mesothelioma
    Kirschner, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S12 - S12